For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Takeda Vaccines, Inc.

USPTO Granted Patents = 72

% Expired Patents = 19.4

CIPO Patents = 2

EPO Patents = 23

Forward Citations = 216

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Dan T Stinchcomb (24 out of 57 patents)

Jill Ann Livengood (21 out of 21 patents)

Charles Richardson (19 out of 22 patents)

4. Jorge E Osorio (18 out of 24 patents)

5. Thomas R Foubert (17 out of 20 patents)

6. Thomas S Vedvick (13 out of 50 patents)

7. Joel R Haynes (10 out of 12 patents)

8. William T Tino (10 out of 17 patents)

9. Timothy D Powell (7 out of 7 patents)

10. Joseph N Brewoo (7 out of 7 patents)

11. Claire Kinney (6 out of 7 patents)

12. Richard M Kinney (6 out of 19 patents)

13. Bryan Steadman (6 out of 7 patents)

14. Hansi Dean (6 out of 6 patents)

15. Charalambos D Partidos (5 out of 5 patents)

Core Competencies:

Dengue Vaccine

Zika Vaccine

Norovirus Vaccine

Virus-Like Particles

Vaccine Formulations

Viral Purification

Chimeric Constructs

Immunogenic Compositions

Flavivirus Stabilization

Live Attenuated Viruses

Reverse Transcriptase Activity

Vaccine Administration

72 patents: Sort by Forward Citations

1. 12734230 - Compositions and methods for stabilizing flaviviruses with improved formulations (2026-09-15),

2. D1123612 - Pharmaceutical packaging (2026-04-28),

3. 12479891 - METHODS OF DETECTION AND REMOVAL OF RHABDOVIRUSES FROM CELL LINES (2025-11-25),

4. 12286456 - Purification of virus like particles (2025-04-29),

5. 12201683 - Methods for preventing dengue and hepatitis a (2025-01-21),

6. 12186363 - Compositions and methods for dengue virus chimeric constructions in vaccines (2025-01-07),

7. D1054846 - Pharmaceutical packaging (2024-12-24),

8. 12109260 - Zika vaccines and immunogenic compositions, and methods of using the same (2024-10-08),

9. 12018052 - Methods of detection and removal of rhabdoviruses from cell lines (2024-06-25),

10. 12006341 - Methods of detection and removal of rhabdoviruses from cell lines (2024-06-11),

11. 11975062 - Zika vaccines and immunogenic compositions, and methods of using the same (2024-05-07),

12. 11964008 - Method for inactivating zika virus and for determining the completeness of inactivation (2024-04-23),

13. 11931399 - Compositions and methods for dengue virus chimeric constructions in vaccines (2024-03-19),

14. 11826415 - Method of conferring a protective immune response to Norovirus (2023-11-28),

15. 11730802 - Zika vaccines and immunogenic compositions, and methods of using the same (2023-08-22),

Company Overview

Takeda Vaccines, Inc., based in Cambridge, MA, specializes in the development of innovative vaccines targeting infectious diseases. The company focuses on advanced technologies such as virus-like particles and chimeric constructs to create effective immunogenic compositions. Its research encompasses vaccines for dengue, Zika, and norovirus, emphasizing viral purification and tailored vaccine formulations. Takeda Vaccines is committed to addressing global health challenges through cutting-edge vaccine solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

72 Patents

#38 in Cambridge, MA

#283 in Massachusetts

#5,106 in US

#10,392 in the World

Cambridge, MA, United States of America

Takeda Vaccines, Inc.

Forward Citations = 216

52 inventors:

Dan T Stinchcomb (24 out of 57 patents)

Jill Ann Livengood (21 out of 21 patents)

Charles Richardson (19 out of 22 patents)

4. Jorge E Osorio (18 out of 24 patents)

5. Thomas R Foubert (17 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Takeda Vaccines, Inc.. Retrieved from https://idiyas.com/company/takeda-vaccines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…